(XMVM) Invesco S&P MidCap Value - Ratings and Ratios
Mid-Cap, Value, Momentum, Stocks, S&P-400
Dividends
| Dividend Yield | 1.92% |
| Yield on Cost 5y | 3.85% |
| Yield CAGR 5y | 12.24% |
| Payout Consistency | 93.5% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 17.4% |
| Value at Risk 5%th | 27.7% |
| Relative Tail Risk | -3.30% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.46 |
| Alpha | -0.07 |
| CAGR/Max DD | 0.70 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.494 |
| Beta | 0.919 |
| Beta Downside | 0.950 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.12% |
| Mean DD | 5.67% |
| Median DD | 4.39% |
Description: XMVM Invesco S&P MidCap Value October 27, 2025
The Invesco S&P MidCap Value with Momentum ETF (NYSE ARCA: XMVM) aims to track an index that selects 80 stocks from the S&P MidCap 400® based on a combined “value” and “momentum” scoring methodology, allocating at least 90% of assets to those securities.
Key characteristics: • Ticker XMVM, classified as a U.S. “Small Value” ETF. • The underlying index emphasizes mid-cap equities that exhibit low price-to-earnings (P/E) and price-to-book (P/B) ratios while also showing positive price momentum over the past 12 months. • As of the latest quarter, the fund’s average dividend yield sits around 2.1%, and its expense ratio is 0.30%, which is modest relative to peers.
Drivers to watch: 1. U.S. mid-cap earnings growth, which historically outpaces large-cap growth in early-cycle environments. 2. Monetary-policy shifts: tighter rates can compress valuation multiples, potentially benefiting the value tilt of the portfolio. 3. Sector exposure-approximately 30% of holdings are in industrials and financials, sectors that tend to be sensitive to interest-rate changes and capital-expenditure cycles.
For a deeper, data-rich analysis of XMVM’s risk-adjusted performance and how its value-momentum blend behaves across market regimes, you might find the ValueRay platform useful.
What is the price of XMVM shares?
Over the past week, the price has changed by +3.66%, over one month by +7.46%, over three months by +5.90% and over the past year by +13.60%.
Is XMVM a buy, sell or hold?
What are the forecasts/targets for the XMVM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 75.7 | 15.2% |
XMVM Fundamental Data Overview December 02, 2025
Beta = 1.21
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 329.5m USD (329.5m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 329.5m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 329.5m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.40% (E(329.5m)/V(329.5m) * Re(9.40%) + (debt-free company))
Discount Rate = 9.40% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for XMVM ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle